Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Philadelphia Chromosome-Negative Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00390793
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.

Who this might be right for
Acute Lymphoblastic LeukemiaBCR-ABL1 Fusion Protein ExpressionBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
M.D. Anderson Cancer Center 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT07199855
What this trial is testing

Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia, Adult
Zhejiang University 24
Large-scale testing (Phase 3)Study completedNCT00327678
What this trial is testing

Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

Who this might be right for
Leukemia, Lymphocytic
Assistance Publique - Hôpitaux de Paris 1,080
Testing effectiveness (Phase 2)Looking for participantsNCT07039877
What this trial is testing

Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients

Who this might be right for
Acute Lymphobkastic LeukemiaAcute Lymphoblastic Leukaemia RecurrentPhiladelphia Chromosome Negative ALL
Hospital Universitario Dr. Jose E. Gonzalez 12
Testing effectiveness (Phase 2)Study completedNCT00388895
What this trial is testing

Glivec in Ph Positive Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaCromosome Philadelphia Positive
PETHEMA Foundation 35
Not applicableLooking for participantsNCT06237192
What this trial is testing

MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
National Research Center for Hematology, Russia 200
Large-scale testing (Phase 3)Looking for participantsNCT06051409
What this trial is testing

Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Who this might be right for
Ph+ ALLLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc. 350
Testing effectiveness (Phase 2)Looking for participantsNCT04747912
What this trial is testing

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

Who this might be right for
Lymphoblastic LeukemiaAcute Lymphoblastic Leukemiaph+ Acute Lymphoblastic Leukemia
University of Chicago 25
Testing effectiveness (Phase 2)Looking for participantsNCT07227584
What this trial is testing

ALL Backbone in AYAs

Who this might be right for
Acute Lymphoblastic LeukemiaPhiladelphia Chromosome-Negative Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia (ALL)+1 more
Dana-Farber Cancer Institute 67
Testing effectiveness (Phase 2)Looking for participantsNCT07252336
What this trial is testing

Study of CAR-T Cells in Primary Ph+All

Who this might be right for
ALL
Zhejiang University 50
Post-approval studies (Phase 4)UnknownNCT01358201
What this trial is testing

PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 100
Post-approval studies (Phase 4)Study completedNCT00853008
What this trial is testing

Treatment of High Risk Adult Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
PETHEMA Foundation 100
Testing effectiveness (Phase 2)Study completedNCT00061945
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Acute Undifferentiated LeukemiaB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic Leukemia+11 more
National Cancer Institute (NCI) 302
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453500
What this trial is testing

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
University of Washington 32
Testing effectiveness (Phase 2)Study completedNCT04554485
What this trial is testing

Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Lymphoblastic Leukemia, Acute, AdultPh Negative ALLNewly Diagnosed
Institute of Hematology and Blood Transfusion, Czech Republic 27
Testing effectiveness (Phase 2)Looking for participantsNCT07387926
What this trial is testing

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00458848
What this trial is testing

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 470
Testing effectiveness (Phase 2)WithdrawnNCT05114837
What this trial is testing

Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL

Who this might be right for
Lymphoma Leukemia
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT01004497
What this trial is testing

First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALL

Who this might be right for
Acute Lymphoblastic Leukemia
The Catholic University of Korea 51
Early research (Phase 1)Study completedNCT01077544
What this trial is testing

A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
Novartis Pharmaceuticals 15
Next Page